PDS Biotechnology Corporation (NASDAQ: PDSB)
$4.14
-0.0850 ( -2.01% ) 601.9K
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It isĀ engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Market Data
Open
$4.14
Previous close
$4.23
Volume
601.9K
Market cap
$152.04M
Day range
$4.03 - $4.42
52 week range
$2.53 - $6.85
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 16 | Mar 13, 2024 |
4 | Insider transactions | 1 | Jan 23, 2024 |
3 | Insider transactions | 1 | Jan 23, 2024 |
8-k | 8K-related | 14 | Jan 22, 2024 |
8-k | 8K-related | 67 | Dec 04, 2023 |
3 | Insider transactions | 1 | Dec 04, 2023 |
4 | Insider transactions | 1 | Dec 04, 2023 |
8-k | 8K-related | 13 | Nov 28, 2023 |
8-k | 8K-related | 13 | Nov 14, 2023 |
10-q | Quarterly Reports | 57 | Nov 14, 2023 |